Back to DEUTSCHE BANK AG\ DEUTSCHE BANK AG\

COGTCOGT
Showing 8 of 21 quarters

Position history for DEUTSCHE BANK AG\DEUTSCHE BANK AG\'s holdings in Cogent Biosciences, Inc.

DEUTSCHE BANK AG\ holds 266,584 shares of COGT (Cogent Biosciences, Inc.), worth $10.3M as of 2026-Q2. The position was increased (+109.1% shares). COGT represents 0.0% of DEUTSCHE BANK AG\'s portfolio.

Current Value

$10.3M

Current Shares

266,584

Total Value Change

+$8.6M

Total Shares Change

+103,726

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
266,584
+109.1%
$10.3M0.0%$38.70
45
2026-Q1
Increased
127,469
+16.8%
$4.9M0.0%$37.24
31
2025-Q4
Increased
109,128
+13.5%
$3.9M0.0%$37.12
30
2025-Q3
Increased
96,127
+66.5%
$1.4M0.0%$14.13
37
2025-Q2
Decreased
57,730
-18.6%
$414,5010.0%$7.10
0
2025-Q1
Decreased
70,897
-10.6%
$424,6740.0%$6.48
0
2024-Q4
Decreased
79,265
-51.3%
$618,2670.0%$7.71
0
2024-Q3
Decreased
162,858
-31.7%
$1.8M0.0%$10.90
0

Other major holders of COGT: FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used